You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / ABIM MOC

Does Your Patient Have Steatotic Liver Disease? A Virtual Patient Challenge

  • Authors: Manal F. Abdelmalek, MD; Kenneth Cusi, MD
  • CME / ABIM MOC Released: 10/27/2023
  • Valid for credit through: 10/27/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.00 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for diabetologists, endocrinologists, primary care physicians, and gastroenterologists.

The goal of this activity is for learners to be better able to risk-stratify patients with risk factors for metabolic dysfunction-associated steatohepatitis (MASH) and recommend evidence- and guideline-based management strategies.

Upon completion of this activity, participants will:

  • Demonstrate improved performance associated with
    • Risk-stratifying patients with identified risk factors for MASH
    • Staging and monitoring metabolic dysfunction-associated steatoic liver disease (MASLD)/MASH with noninvasive tests and other modalities
    • Early management of MASH and metabolic disease in accordance with evidence-based guidelines


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Manal F. Abdelmalek, MD

    Professor of Medicine
    Duke University
    Durham, North Carolina

    Disclosures

    Manal F. Abdelmalek, MD, has the following relevant financial relationships:
    Consultant or advisor for: 89Bio Inc; Bristol Myers Squibb; Hanmi Pharm; Intercept Pharmaceuticals; Inventiva; Madrigal Pharmaceuticals; Merck & Co., Inc.; NGM Bio; Novo Nordisk; Sonic Incytes; Theratechnologies
    Speaker or member of speakers bureau for: Fishawack Health; Terra Firma
    Research funding from: Allergan; Boehringer Ingelheim; Bristol Myers Squibb; Celgene; Durect Corporation; Enanta Pharma; ENYO Pharma; Galmed Pharmaceuticals; Genentech; Gilead Sciences; Hanmi Pharm; Intercept Pharmaceuticals; Inventiva; Madrigal Pharmaceuticals; Novo Nordisk; Poxel; TARGET-NASH; Viking Therapeutics

  • Kenneth Cusi, MD

    Professor of Medicine
    Division of Endocrinology, Diabetes and Metabolism
    The University of Florida
    Gainesville, Florida

    Disclosures

    Kenneth Cusi, MD, has the following relevant financial relationships:
    Consultant or advisor for: Aligos Therapeutics; Altimmune; Arrowhead Pharmaceuticals; AstraZeneca; Boehringer Ingelheim; Covance; 89Bio Inc; Bristol Myers Squibb; Lilly; Madrigal Pharmaceuticals; Merck & co., Inc.; Myovant Sciences; Novo Nordisk; ProSciento; Sagimet Biosciences; Siemens Healthcare Diagnostics; Sonic Incytes; Terns Pharmaceuticals
    Research funding from: Echosens; Inventiva; Nordic Bioscience; Labcorp; TARGET-NASH

Editors

  • Jennifer Hakkarainen, PA-C

    Medical Education Director, Medscape, LLC

    Disclosures

    Jennifer Hakkarainen, PA-C, has no relevant financial relationships.

  • Katie Prince

    Writer, Chichester Associates, Phoenix, Arizona

    Disclosures

    Katie Prince has no relevant financial relationships.

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Does Your Patient Have Steatotic Liver Disease? A Virtual Patient Challenge

Authors: Manal F. Abdelmalek, MD; Kenneth Cusi, MDFaculty and Disclosures

CME / ABIM MOC Released: 10/27/2023

Valid for credit through: 10/27/2024, 11:59 PM EST

processing....

ABOUT THIS ACTIVITY
Learn to better manage patients with risk factors for steatotic liver disease.

Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface.

Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.

patient simulation
  • Print